FDA Device Intelligence
Home › Siemens Healthcare Diagnostics Inc. › Stratus® CS Acute Care™ CCRP TestPak

Stratus® CS Acute Care™ CCRP TestPak

Siemens Healthcare Diagnostics Inc. · Model 10445066 · UDI-DI 00842768004469

JHX
1
510(k) clearances
189
Adverse events
15
Recalls
31
Facilities

Description

The Stratus® CS Acute Care™ CardioPhase® high sensitivity CRP method (hsCRP) is an in vitro diagnostic reagent for the quantitative determination of C-reactive protein (CRP) in lithium and sodium heparin plasma and is intended to be used on the Stratus® CS analyzer.

Recalls

DateFirmReason
2025-03-31Siemens Healthcare Diagnostics IncSiemens Healthcare Diagnostics Inc., is recalling their Stratus CS Acute Care cTNI TestPak, an IVD test for cardiac troponin I in heparinized plasma by removal. The reason for the
2018-04-30Polymedco, Inc.,/Polymedco Cancer Diagnostic Products, LlcA pinhole caused by the laser printer in the aluminum sheet over the ALP reagent wells caused leakage through the pinhole. If the cartridge with leakage is used, higher measurement
2018-03-05Tosoh Bioscience IncAsfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.
2016-06-22Siemens Healthcare Diagnostics IncSoftware defect, where either an Above Assay Range or an inaccurate value could potentially be reported, in the Stratus CS Acute Care Diagnostics System regarding TestPak calibrati
2015-11-11Siemens Healthcare Diagnostics IncStratus CS Cartridge Barcode labels may not scan on the Stratus CS systems
2015-11-11Siemens Healthcare Diagnostics IncStratus CS Cartridge Barcode labels may not scan on the Stratus CS systems
2012-01-25Siemens Healthcare DiagnosticsSiemens Healthcare Diagnostics has observed that the median for the reference range with current kit lots of the CK-MB assay differs from the guidelines published in the Instructio
2012-01-25Siemens Healthcare DiagnosticsSiemens Healthcare Diagnostics has observed that the median for the reference range with current kit lots of the CK-MB assay differs from the guidelines published in the Instructio
2012-01-25Siemens Healthcare DiagnosticsSiemens Healthcare Diagnostics has observed that the median for the reference range with current kit lots of the CK-MB assay differs from the guidelines published in the Instructio
2012-01-25Siemens Healthcare DiagnosticsSiemens Healthcare Diagnostics has observed that the median for the reference range with current kit lots of the CK-MB assay differs from the guidelines published in the Instructio

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.